C1q: A Multifunctional Ligand for a New Immunoadsorption Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

C1q: A Multifunctional Ligand for a New Immunoadsorption Treatment

Published:1999-08 Issue:3 Volume:3 Page:246-251
ISSN:1091-6660
Container-title:Therapeutic Apheresis
language:en
Short-container-title:Therapeutic Apheresis

Author:

Hiepe Falk¹,Pfüller Barbara¹,Wolbart Karsten²,Bruns Anne¹,Leinenbach Hans‐Peter³,Hepper Martin³,Schößler Werner⁴,Otto Veit³

Affiliation:

1. Department of Internal Medicine (Rheumatology and Clinical Immunology), University Hospital Charité, Humboldt‐University, Berlin, Germany,

2. Outpatients Department, University Hospital Charité, Humboldt‐University, Berlin, Germany,

3. Fresenius AG, St. Wendel, Germany,

4. Imtec Immundiagnostika, Berlin‐Buch, Germany

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1091-6660.1999.t01-2-.x

Reference36 articles.

1. Die Fähigkeit des Blutes Bacterien zu vernichten

2. Zur Theorie der Lysenwirkung.;Ehrlich P;Berl Klin Wschr,1899

3. C1 the first component of complement. Histories and mysteries about C1.;Borsos T;Behring Inst Mitt,1989

4. CHROMATOGRAPHIC RESOLUTION OF THE FIRST COMPONENT OF HUMAN COMPLEMENT INTO THREE ACTIVITIES

5. QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A reverse translational study on the effect of rituximab, rituximab plus belimumab, or bortezomib on the humoral autoimmune response in SLE;Rheumatology;2020-01-17

2. Immunoadsorption in Autoimmune Diseases Affecting the Kidney;Seminars in Nephrology;2017-09

3. Therapeutic Apheresis in Hematologic, Autoimmune and Dermatologic Diseases With Immunologic Origin;Therapeutic Apheresis and Dialysis;2016-09-16

4. Complimentary action: C1q increases ganglion cell survival in an in vitro model of retinal degeneration;Journal of Neuroimmunology;2016-09

5. Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review;Autoimmunity Reviews;2016-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3